Fiera Capital (Canada)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,054
Closed -$237K 654
2017
Q1
$237K Sell
2,054
-160,509
-99% -$18.7M ﹤0.01% 589
2016
Q4
$19.5M Sell
162,563
-45,925
-22% -$5.08M 0.11% 182
2016
Q3
$23.4M Sell
208,488
-8,264
-4% -$952K 0.13% 170
2016
Q2
$26.9M Buy
+216,752
New +$26.2M 0.15% 160
2015
Q4
Sell
-63,170
Closed -$6.3M 586
2015
Q3
$6.3M Buy
63,170
+785
+1% +$85.4K 0.05% 168
2015
Q2
$7.11K Buy
62,385
+2,296
+4% +$278K 0.04% 173
2015
Q1
$6.28M Buy
+60,089
New +$6.4M 0.05% 196
2014
Q2
Sell
-15,732
Closed -$3.12M 502
2014
Q1
$3.12M Buy
15,732
+2,121
+16% +$400K 0.02% 269
2013
Q4
$2.6M Buy
+13,611
New +$2.53M 0.02% 283

Other funds holding CLB

Fiera Capital (Canada)'s CLB Position: Q2 2017 in Review

Fiera Capital (Canada) sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 2,054 shares — an estimated $237K sold.

Fiera Capital (Canada) first reported a position in CLB in Q4 2013 and held it in 9 quarters. The position peaked at $26.9M in Q2 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • Fiera Capital (Canada) reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • Fiera Capital (Canada) sold 2,054 Core Laboratories shares in Q2 2017, an estimated $237K.
  • Fiera Capital (Canada) first reported a position in Core Laboratories in Q4 2013 and held it in 9 quarters.
  • Fiera Capital (Canada)'s Core Laboratories position peaked at $26.9M in Q2 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2017, filed 10 Aug 2017.